Norwich Ventures

Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies. Its imaging technology surpasses light microscopy to analyze whether the tissues are fresh, frozen, or FFPE that enable healthcare providers to provide a diagnosis of cancer for improving human health.

Podimetrics is a care management company with the leading solution to help prevent diabetic foot ulcers (DFU), one of the most debilitating and costly complications of diabetes. On behalf of payers and at-risk providers, we send high-risk patients our FDA-cleared, cellular-connected SmartMat. After placing their feet on the mat for just 20 seconds a day, patients’ data are automatically sent to our care management team that triages any concerning findings. By combining cutting-edge technology with best-in-class care management, Podimetrics earns high engagement rates from patients and allows clinicians to achieve unparalleled outcomes saving limbs, lives, and money. Founded in 2011 by a physician and engineers from MIT and Harvard, Podimetrics is headquartered in Somerville, MA and backed by Norwich Ventures, Scientific Health Development, and Rock Health. For more information, go to www.podimetrics.com or follow us on Twitter @podimetrics.

Podimetrics is a care management company with the leading solution to help prevent diabetic foot ulcers (DFU), one of the most debilitating and costly complications of diabetes. On behalf of payers and at-risk providers, we send high-risk patients our FDA-cleared, cellular-connected SmartMat. After placing their feet on the mat for just 20 seconds a day, patients’ data are automatically sent to our care management team that triages any concerning findings. By combining cutting-edge technology with best-in-class care management, Podimetrics earns high engagement rates from patients and allows clinicians to achieve unparalleled outcomes saving limbs, lives, and money. Founded in 2011 by a physician and engineers from MIT and Harvard, Podimetrics is headquartered in Somerville, MA and backed by Norwich Ventures, Scientific Health Development, and Rock Health. For more information, go to www.podimetrics.com or follow us on Twitter @podimetrics.

Affera is a medical technology company dedicated to developing innovative solutions for the treatment of cardiac arrhythmia, a prevalent condition affecting millions of patients worldwide.

ReThink Medical is a medical device and digital health company developing a wrist-worn monitoring device. Our technology is designed to predict and prevent heart failure hospitalizations through compliance-centric continuous physiologic monitoring & machine learning. Our product, CorBand™ uses state of the art algorithms and artificial intelligence to potentially detect worsening conditions weeks in advance - even before noticeable symptoms. Data-driven therapy can allow ample time for proper treatment to prevent hospitalization, improve quality of life, and save billions in healthcare costs. We've designed a proactive approach to managing heart failure patients with a focus on compliance, simplicity, and accuracy.

Pelvalon is a medical device company that develops products for women suffering from fecal incontinence. They help women achieve bowel control.

We are a Boston-based medical device company that manufactures minimally invasive surgical stapling solutions. With the highest standards in design engineering and smart manufacturing, our specialized team is committed to delivering disruptive innovation to health care providers and their patients.

Soffio Medical is a medical company that develops medical apparatus for respiratory diseases. The company is based in Boston, Massachusetts.

Arterys is the market leader and the world's first internet platform for medical imaging. Its objective is to transform healthcare by transforming radiology. The Arterys platform is 100% web-based, AI-powered, and FDA-cleared, unlocking simple clinical solutions.

Arterys is the market leader and the world's first internet platform for medical imaging. Its objective is to transform healthcare by transforming radiology. The Arterys platform is 100% web-based, AI-powered, and FDA-cleared, unlocking simple clinical solutions.

Daktari Diagnostics was founded to create products that address the most pressing challenges in global health. These problems include not only better diagnosis of disease, but also the communication of data throughout the healthcare system. We are committed to delivering critical diagnostic test results to clinicians and patients across the globe. Our team of engineers, scientists, physicians, and global health experts is uniquely dedicated to making high-performance products specifically designed for resource-poor markets. We recognize that information can only be useful if it can move. Daktari’s products are connected in the field, allowing clinical, quality, and performance data to flow where it needs to go. We strive to provide quality products at an affordable price, and to support our products when used by anyone, anywhere in the world. We strive to treat our customers, our partners, and our colleagues with kindness, as equals, and to be a positive force in our communities and in the world.

Vaxess Technologies is developing the MIMIX™ sustained release patch technology, the easiest and most effective way to administer vaccines and therapeutics. For vaccines, the controlled release simulates the pace of a natural infection, helping the body produce a slow, strong, and enduring ramp-up of immune response, ultimately boosting a vaccine’s effectiveness. Engineered for stability, Vaxess’s patch does not require refrigeration and can be shipped to and applied in low resource settings.

Daktari Diagnostics was founded to create products that address the most pressing challenges in global health. These problems include not only better diagnosis of disease, but also the communication of data throughout the healthcare system. We are committed to delivering critical diagnostic test results to clinicians and patients across the globe. Our team of engineers, scientists, physicians, and global health experts is uniquely dedicated to making high-performance products specifically designed for resource-poor markets. We recognize that information can only be useful if it can move. Daktari’s products are connected in the field, allowing clinical, quality, and performance data to flow where it needs to go. We strive to provide quality products at an affordable price, and to support our products when used by anyone, anywhere in the world. We strive to treat our customers, our partners, and our colleagues with kindness, as equals, and to be a positive force in our communities and in the world.

Syncro Medical Innovations, Inc. develops magnetically guided enteral feeding tubes. The company’s feeding tube contains magnetic field sensor at the distal end, electrically connected to a light indicator at the proximal end of the tube. Syncro Medical Innovations, Inc. was founded in 1998 and is based in Macon, Georgia.

Svelte Medical Systems (Svelte) is a privately held company focused on delivering novel products in the $5 billion coronary stent market. Its mission is to address key clinical issues in the stent market by improving stent deliverability, reducing cost, and dramatically improving the safety of the device compared to current market products. Svelte has developed the lowest profile and most deliverable balloon-expandable stent in the market, along with technology to create a non-thrombogenic, non-inflammatory Drug-Eluting Stent (DES). Svelte was started by Robert Fischell, David Fischell, and Tim Fischell in 2007.

Daktari Diagnostics was founded to create products that address the most pressing challenges in global health. These problems include not only better diagnosis of disease, but also the communication of data throughout the healthcare system. We are committed to delivering critical diagnostic test results to clinicians and patients across the globe. Our team of engineers, scientists, physicians, and global health experts is uniquely dedicated to making high-performance products specifically designed for resource-poor markets. We recognize that information can only be useful if it can move. Daktari’s products are connected in the field, allowing clinical, quality, and performance data to flow where it needs to go. We strive to provide quality products at an affordable price, and to support our products when used by anyone, anywhere in the world. We strive to treat our customers, our partners, and our colleagues with kindness, as equals, and to be a positive force in our communities and in the world.

Intelligent Bio-Systems was founded in 2005 by Drs. Steven J. Gordon and Jingyue Ju to commercialize an advanced DNA sequencing system. Dr. Gordon previously founded Intelligent Automation Systems, which was responsible for a number of key instrumentation solutions which helped to complete the Human Genome Project. Dr. Ju is one of the key inventors of fluorescent energy transfer dyes used in most electrophoresis-based sequencers.

Rhythmia Medical, Inc., an early stage medical device company, develops medical devices for the treatment of cardiac arrhythmia. It focuses on developing a 3D mapping system to enable an improvement in the catheter ablation procedures used to treat tachy-arrhythmias, such as atrial fibrillation.

Syncro Medical Innovations, Inc. develops magnetically guided enteral feeding tubes. The company’s feeding tube contains magnetic field sensor at the distal end, electrically connected to a light indicator at the proximal end of the tube. Syncro Medical Innovations, Inc. was founded in 1998 and is based in Macon, Georgia.